Join to View Full Profile
Lilly Corporate CtrBldg 48/2Indianapolis, IN 46285
Phone+1 317-651-9993
Dr. Blanchard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Indiana University School of MedicineClass of 1985
Certifications & Licensure
IN State Medical License 2000 - 2025
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 16 citationsA Novel Eg5 Inhibitor (LY2523355) Causes Mitotic Arrest and Apoptosis in Cancer Cells and Shows Potent Antitumor Activity in Xenograft Tumor ModelsXiang S. Ye, Li Fan, Robert D. Van Horn, Ryuichiro Nakai, Yoshihisa Ohta
Molecular Cancer Therapeutics. 2015-08-24 - 60 citationsCdk1 Activity Is Required for Mitotic Activation of Aurora A during G2/M Transition of Human CellsRobert D. Van Horn, Shaoyou Chu, Li Fan, Tinggui Yin, Jian Du
The Journal of Biological Chemistry. 2010-07-09 - 294 citationsTherapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicityJeremy R. Graff, Bruce W. Konicek, Thomas M. Vincent, Rebecca L. Lynch, David Monteith
The Journal of Clinical Investigation. 2007-09-04
Press Mentions
Gilead to Acquire Remaining Worldwide Rights of Trodelvy®August 15th, 2022- Everest Medicines Announces Approval of Trodelvy® in China for Second-Line Metastatic Triple-Negative Breast CancerJune 10th, 2022
- Everest Medicines' Licensing Partner Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod's Potentially Best-in-Class Profile in Ulcerative ColitisMay 24th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
